Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Unexpected effect of famous antibiotic on fungal microbiota
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Unexpected effect of famous antibiotic on fungal microbiota
Gastroenterology

Unexpected effect of famous antibiotic on fungal microbiota

Antibiotics
Gastroenterology

Until recently, antibiotics had been thought to promote fungal growth. However, a study published in Microbiome suggests that amoxicillin/clavulanic acid reduces the gut mycobiota’s fungal load. This unexpected effect is undoubtedly linked to an increase in Enterobacteriaceae species and reveals the delicate balance between bacteria and fungi in the gut microbiota.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 26 July 2023
Updated 31 October 2023

In studies of the gut microbiota, fungi have long been overlooked, with the focus instead falling on bacteria, the main microorganisms found in the gut. We still have a limited understanding of how fungi interact with bacterial communities in the gut microbiota and of how antibiotics impact the gut mycobiota. French researchers have tried to shed some light on the matter by studying the effect of amoxicillin/clavulanic acid (AMC) on bacteria and fungi in the gut microbiota of mice and infants.

Unexpected, antibiotic-dependent fall in gut fungal load 

Their study on conventional mice showed, as expected, that AMC administered for ten days reduced the amount of bacteria present in the feces and gut. Far more surprising, the treatment also greatly reduced the overall fungal population compared to controls. A “cocktail” of broad-spectrum antibiotics (ampicillin, metronidazole, neomycin, and vancomycin [VA]...), had the same impact. However, mice that received a fecal microbiota transplant (FMT) from healthy adult humans showed a response in their mycobiota that was antibiotic-dependent: the fungal load was again lower with amoxicillin/clavulanic acid but increased with VA. In parallel, the researchers analyzed 19 gut microbiota samples from 7 infants aged 2 to 4 months treated for otitis media with amoxicillin. This antibiotic, which is very similar to AMC, also reduced the bacterial and fungal load during treatment.

The ambivalent role of antibiotics

Learn more

Bacterial and fungal balance transformed by amoxicillin/clavulanic acid

The researchers found that the alpha and beta diversity of the fungal population in the feces of conventional mice treated with AMC had decreased, but that the share of Aspergillus, Cladosporium, and Valsa had increased compared to untreated mice. Bacterial alpha-diversity had also decreased, but differential analysis revealed a shift in bacterial families in the gut microbiota after treatment, with an increase in Enterobacteriaceae.

Suspecting a link between the increase in this bacterial family and the reduction in fungal load, the researchers isolated 13 bacteria from the feces of mice treated with AMC and coincubated them with S. cerevisiae. Nine of them inhibited the growth of this yeast, all of which were Enterobacteriaceae. These Enterobacteriaceae, and in particular E. hormaechei, also reduced the growth of Candida albicans. In addition, when colistin, an antibiotic that targets Enterobacteriaceae, was administered to the mice that had received a human FMT, the mice’s gut fungal abundance increased. After further in vitro and in vivo tests to observe the interactions between gut bacteria and fungi, the researchers concluded that Enterobacteriaceae were at least partly involved in the dysbiosis of the gut mycobiota caused by AMC. Several mechanisms could be at play, including competition for certain nutrients between these bacteria and fungi. 

A change of paradigm? 

Although carried out on mice and a small cohort of infants, this study challenges the preconceived idea that all antibiotics promote the proliferation of fungi in the gut microbiota. Amoxicillin/clavulanic acid, a widely prescribed antibiotic, decreases the overall abundance of the gut fungal population and remodels gut microbiota composition in terms of fungal and bacterial species. The study also reveals the close links between bacteria and fungi in the gut microbiota via the complex alterations in the balance of their populations that antibiotics can provoke. Confirmation of these results on larger cohorts may lead to changes in medical practice, particularly in situations where the mycobiota plays a significant role in patient health.

What is the World AMR Awareness Week?

Each year, since 2015, the WHO organizes the World AMR Awareness Week (WAAW), which aims to increase awareness of global antimicrobial resistance.
Held on 18-24 November, this campaign encourages the general public, healthcare professionals and decision-makers to use antimicrobials carefully, to prevent the further emergence of antimicrobial resistance.

"Excellent" -Asana Assane (From Biocodex Microbiota Institute on X)

Sources

Spatz M, Da Costa G, Ventin-Holmberg R, et al. Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem. Microbiome. 2023;11(1):73

Tags
Microbiome Flora

    See also

    Antibiotiques : le mycobiote des nourrissons sous influence The effect of antibiotics on infant mycobiota
    Actu PRO : Spondylarthrite ankylosante : le microbiote fongique également en cause Ankylosing spondylitis: the role of fungal microbiota
    Created 26 July 2023
    Updated 31 October 2023

    About this article

    To know more about this topic.

    Main topic

    Antibiotics

    Medical practice

    Gastroenterology

    Content type

    News
    Gastroenterology

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irrita...

    Find out more

    Probiotics: what exactly are we talking about?

    From the Latin pro and Greek bios meaning “for life”, the term “probiotic” was suggested over 60 year...

    Find out more

    How do you choose a probiotic for your patient?

    Faced with a plethora of products on the market, it's not always easy for health professionals to sug...

    Find out more

    The Janus face of Antibiotics: Life Savers and Microbiota Disruptors

    A page turns: with the advent of antibiotics in the...

    Find out more

    Fecal transplantation - ready for prime time?

    Congress review By Pr. Danny De Looze Department of Gastroenterology University Hospital Gent, Belgi...

    Find out more

    Focus on antibiotic associated diarrhea (AAD)

    Find out more

    Dampening gastrointestinal inflammation through nutrition

    by Dr Genelle Healey

    Find out more

    Continue reading

    News
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    07.02.2025

    Your functional dyspepsia diagnosis check list

    Read the article
    17.04.2025

    Sensitivity to the additive E466: the role of the microbiota

    Read the article
    Photo HCPs: Clinical context over quick fix: the fresh consensus on microbiome testing
    11.04.2025

    Clinical context over quick fix: the fresh consensus on microbiome testing

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    Actu PRO : Alcoolisme : expliquer les troubles sociaux grâce au microbiote
    27.01.2021

    Alcoholism: explaining social disorders thanks to the microbiota

    Read the article
    20.03.2025

    Entacapone and the gut: a hidden impact on parkinson’s care

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo